TWST News and Press, Twist Bioscience Corporation From 01/11/23

Summary Let's continue our roundtable series with Growth, Tech and Crypto, and Quantitative, Technical analysis coverage. Nine of our Marketplace contributors give their analysis and share one top idea. We end the series with Biotech and Healthcare coverage. ~ By Ashutosh Go...

Combining expertise to advance precision medicine, while enabling efficient and timely insights into the diagnosis of rare diseases and hereditary cancer around the world Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offerin...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a research collaboration with Astellas Pharma Inc . (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D.,...

Summary Twist operates in a trendy space, with good growth, but atrocious margins. As profits are not in the company’s DNA, losses are likely to continue. Although the stock is down a lot, it still trades at a healthy valuation. The stock has limited downside protection i...

Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, will present at the 41st Annual J.P. Morgan He...

New York, New York--(Newsfile Corp. - December 20, 2022) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit. The lawsuit on behalf of Twist investors has been commenced in the the United ...

Boston, Massachusetts--(Newsfile Corp. - December 19, 2022) - Block & Leviton announces that a class action lawsuit has been filed against Twist Bioscience Corp. (NASDAQ: TWST) for securities law violations. Investors who purchased shares and have lost money are encouraged to contact the fir...

New York, New York--(Newsfile Corp. - December 16, 2022) - Levi & Korsinsky, LLP notifies investors in Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ: TWST) of a class action securities lawsuit. The lawsuit on behalf of Twist investors has been commenced in the the United ...

NEW YORK, NY / ACCESSWIRE / December 14, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Twist Bioscience Corporation ("Twist" or the "Company") (NASDAQ:TWST) and reminds investors of the February 10, 2023 deadline to seek the ro...

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Twist To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - December 13, 2022) - Faruqi & Faruqi, LLP, a leading national securities law firm, i...